Company / Profit Margin
Lilly (Eli) Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
31.7%
FY2025
5-year range
19.7% / 37.3%
FY2021-FY2025
Trend
+34.7%
vs FY2024
Sector context
#17 of 145
Health Care
What the data says
Lilly (Eli)'s profit margin of 31.7% is higher than 88% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 10 years, ranging from 12.1% in FY2017 to 37.3% in FY2021.
Based on SEC 10-K filings.
31.7% in FY2025 with a 5-year CAGR of +16.6%. Top quartile in the Health Care sector.
Improved from 19.7% to 31.7% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +6.4pp
- 5-Year Change
- +16.6pp
- 10-Year Change
- -
Sector benchmark
Top 12% in Health CareTop 12% of 145This company 31.7% Sector average -792.7%
▼
+104.0% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 34.7% year-over-year.
- Currently 824.4pp above the Health Care sector average.
- Peak profit margin was recorded in FY2021.
- Lowest profit margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 31.7% | +34.7% |
| FY2024 | 23.5% | +19.3% |
| FY2023 | 19.7% | -21.9% |
| FY2022 | 25.2% | -32.3% |
| FY2021 | 37.3% | +147.8% |
| FY2020 | 15.0% | -59.6% |
| FY2019 | 37.3% | +147.8% |
| FY2018 | 15.0% | +24.6% |
| FY2017 | 12.1% | -6.4% |
| FY2016 | 12.9% | +6.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026